Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPPIE: Polaramine® Infusion Before Extracorporeal Circulation
NCT02675374Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexchlorpheniramine in vasoplegic syndrome (VPS) and hemodynamic instability (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Proportion of patients with abnormal ratio of sympathic-parasympathetic balance (>1.2) at Day 2. Started Jun 2016; status: terminated.
02
Drugs
dexchlorpheniramine
03
Conditions
vasoplegic syndrome (VPS)hemodynamic instability
Beyond the preview
Go deeper on NCT02675374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675374.